发明名称 AFFINITY MATURED CRIg VARIANTS
摘要 <p>PROBLEM TO BE SOLVED: To provide CRIg variants having increased binding affinity to C3b and retaining selective binding to C3b over C3.SOLUTION: A CRIg variant comprises an amino acid substitution in a region selected from among E8-K15, R41-T47, S54-Q64, E85-Q99 and Q105-K111 of a specific amino acid sequence. A DNA fragment encoding CRIg is ligated into a phagemid vector (p3DvlzPDZ-gD) as a wild type control and a template for designing CRIg variants. Then, templates with the TAA stop codon at each residue targeted for randomization are prepared from CJ239 Escherichia coli cells. A soft randomization strategy is used for CRIg variants selection to design libraries. The CRIg variant uses modified competitive phage ELISA in order to estimate binding affinity.</p>
申请公布号 JP2015145369(A) 申请公布日期 2015.08.13
申请号 JP20150023559 申请日期 2015.02.09
申请人 GENENTECH INC 发明人 SIDHU SACHDEV S;LI BING;MENNO VAN LOOKEREN CAMPAGNE;WIESMANN CHRISTIAN
分类号 C07K16/18;A61K39/395;A61P29/00;A61P37/00;C07K19/00;C12N15/09 主分类号 C07K16/18
代理机构 代理人
主权项
地址